Genmab A/S Summons Annual General Meeting
Summary: Genmab to hold Annual General Meeting on April 23, 2008
COPENHAGEN, Denmark, April 7 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) summon the Annual General Meeting on Wednesday April 23, 2008 at 3:00 pm CEST at the Radisson SAS Scandinavia Hotel, Amager Boulevard 70, 2300 Copenhagen S, Denmark.
1. Report of the Board of Directors on the Company's activities during the year.
2. Presentation of the audited Annual Report 2007 for approval and the discharge of the Board of Directors and the Management.
3. Decision as to the settlement of loss according to the approved Annual Report.
The Board of Directors proposes that the year's loss of DKK 373 million be carried forward by transfer to accumulated deficit.
4. Election of members of the Board of Directors.
Pursuant to Article 13 of the Company's Articles of Association, the members of the Board of Directors are elected for periods of three years. The election period for Michael B. Widmer and Karsten Havkrog Pedersen expires at the General Meeting. The Board of Directors proposes to re-elect Michael B. Widmer and Karsten Havkrog Pedersen for a further three-year period.
About Michael B. Widmer
Dr. Widmer is Chairman of our board of directors and has been a member
of our board since March 2002. Dr. Widmer is the former Vice President and
Director of Biological Sciences of Immunex Corporation in Seattle. Prior to
joining Immunex in 1984, he was an assistant professor in Laboratory
Medicine and Pathology at the University of Minnesota. He is a former
Scholar of the Leukemia Society of America. His research has centered on
regulation of the immune and inflammatory response. He has authored over
100 scientific publications. During his tenure at Immunex, Dr. Widmer
pioneered the use of cytokine antagonists, particularly soluble cytokine
receptors, as pharmacologic regul
|SOURCE Genmab A/S|
Copyright©2008 PR Newswire.
All rights reserved